Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). (Q46775067)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). |
scientific article |
Statements
1 reference
Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). (English)
1 reference
1 reference
1 reference
1 reference
Pilar Miralles
1 reference
Alberto Arranz
1 reference
Rafael Delgado
1 reference
Alicia Lorenzo
1 reference
Juan J González-García
1 reference
Rafael Hervás
1 reference
José R Paño
1 reference
Francisco Gaya
1 reference
Antonio Carcas
1 reference
José R Costa
1 reference
José M Peña
1 reference
1 November 2005
1 reference
40
1 reference
3
1 reference
280-287
1 reference